Skip to main content
OpenTrials

Clinical trial condition

Oral Cavity Squamous Cell Carcinoma

Explore clinical trials studying Oral Cavity Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

29 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Oral Cavity Squamous Cell Carcinoma trial results

Not Yet Recruiting

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

NCT07484139

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Emory University Atlanta, Georgia, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT03258554

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 256 locations
View Trial Details

Related conditions